SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) — Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath
SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) — Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath